Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Angioedema | Case report

Olmesartan-medoxomil/telmisartan/vildagliptin overdose

Angioedema

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug overdose
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Kono Y, et al. Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin. BMJ Case Reports 17: No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1136/bcr-2023-259485 [Summarised from an abstract] Kono Y, et al. Acute quadruple extremity compartment syndrome due to angio-oedema after polypharmacy overdose including olmesartan medoxomil, telmisartan and vildagliptin. BMJ Case Reports 17: No. 4, Apr 2024. Available from: URL: https://dx.doi.org/10.1136/bcr-2023-259485 [Summarised from an abstract]
Metadata
Title
Olmesartan-medoxomil/telmisartan/vildagliptin overdose
Angioedema
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57763-y

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Lithium

Case report

Testosterone

Case report

Pembrolizumab

Case report

Nivolumab

Case report

Amiodarone